Injective (INJ) Plummets 90%, Erasing $3.7 Billion in Value

Edgen Crypto

·Feb 14 2026, 09:33

Share to

Share to

Copy link

Key Takeaways

Injective (INJ) experienced a catastrophic market event, with its valuation collapsing due to weak underlying fundamentals and a technical breakdown. The speed and severity of the drop have raised significant concerns about the project's long-term viability.

Injective's market capitalization collapsed 90% on February 14, 2026, falling from $4 billion to just $300 million.
The crash is attributed to a combination of low Total Value Locked (TVL) and the failure to maintain critical technical price levels.
This event severely erodes investor confidence, creating a high risk of further sell-offs and potential exchange delistings.

INJ Market Cap Collapses 90% to $300M

On February 14, 2026, Injective's native token (INJ) suffered a devastating 90% crash, wiping out approximately $3.7 billion in investor value. The project's market capitalization plummeted from a high of $4 billion to a low of $300 million in a rapid sell-off. The price collapse was exacerbated by a technical breakdown, as the token failed to hold key support levels, triggering a cascade of liquidations and stop-loss orders.

Weak Fundamentals Undermine Investor Confidence

The drastic price decline appears rooted in weak on-chain fundamentals. Market analysis points to a persistently low Total Value Locked (TVL) within the Injective ecosystem. For a decentralized finance protocol, a low TVL signals a lack of user adoption and capital commitment, suggesting its previous $4 billion valuation was not supported by underlying activity. This disconnect between market price and fundamental usage has severely damaged investor confidence, raising critical questions about the project's sustainability and increasing the likelihood of further selling pressure.